Zhen Han

Title: Zhen Han - Innovator in Cancer Treatment

Introduction

Zhen Han is a prominent inventor based in Frederick, MD (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on enhancing the effectiveness of cancer therapies by utilizing immune-stimulating agents.

Latest Patents

Zhen Han holds a patent for a therapeutic antitumor combination that involves the co-administration of a Toll-like receptor (TLR) 4 ligand, such as an HMGN1 protein, along with TLR 7 or 8 ligands. This method aims to treat cancer or reduce the incidence of relapse in patients. The patent also describes a nanoparticle delivery platform for the effective co-administration of these ligands, enhancing the immune response against cancer.

Career Highlights

Zhen Han is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this esteemed institution has allowed him to explore groundbreaking approaches to cancer treatment, contributing to the advancement of medical science.

Collaborations

Zhen Han has collaborated with notable colleagues, including Joost J Oppenheim and De Yang. These partnerships have fostered a collaborative environment that promotes innovative research and development in cancer therapies.

Conclusion

Zhen Han's contributions to cancer treatment through his patented methods and collaborative efforts highlight his dedication to improving patient outcomes. His innovative approaches continue to pave the way for advancements in the field of oncology.